Mental Health Clinics in Sterling Hts, MI Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Michael Butkus Phd Lp Pllc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 43200 Dequindre Rd Ste 104, Sterling Hts, MI 48314 Phone: 586-799-4350 Fax: 586-799-4279 |
Jennifer Vinch Md Pllc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 43200 Dequindre Rd, Ste 104, Sterling Hts, MI 48314 Phone: 586-799-4350 Fax: 586-799-4279 |
Laura S Henderson Lmsw Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 43200 Dequindre Rd, Ste 104, Sterling Hts, MI 48314 Phone: 586-799-4350 Fax: 586-799-4279 |
Change Is Possible Counseling Services, Llc Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 2122 15 Mile Rd, Suite B, Sterling Hts, MI 48310 Phone: 586-264-3692 Fax: 586-939-5953 |
News Archive
Doctors reluctant to report colleagues for being impaired, incompetent
The Associated Press: "Your doctor could be drunk, addicted to drugs or outright incompetent, but other physicians may not blow the whistle. A new survey finds that many American physicians fail to report troubled colleagues to authorities, believing that someone else will take care of it, that nothing will happen if they act or that they could be targeted for retribution.
AAN neurologist receives prestigious award at Palatucci Advocacy Leadership Forum
The American Academy of Neurology(AAN) has named neurologist Constantine Moschonas, MD, of Scottsdale, Ariz., as the AAN Donald M. Palatucci Advocacy Leadership Forum Advocate of the Year. Moschonas received his award at the Palatucci Advocacy Leadership Forum on January 14, 2012, in Austin, Texas, for his outstanding work in raising awareness about brain diseases such as Alzheimer's disease, stroke, autism, Parkinson's disease and multiple sclerosis.
Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease
Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.
Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies
BioTime, Inc. Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure will receive an equity investment of $7.1 million from BioTime, Teva Pharmaceutical Industries Ltd., and Hadasit Bio-Holdings (HBL).
Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University published a review for clinicians on the optimal utilization of aspirin to treat and prevent heart attacks.
› Verified 2 days ago